IVUS vs OCT to Guide PCI: Which Should We Choose?

Controlling stent expansion with optical coherence tomography (OCT) based on an external elastic membrane–based protocol for stent sizing resulted non-inferior to the control group which used intravascular ultrasound (IVUS) and superior the angiography only group. Based on these study outcomes and the prior outcomes, we should use IVUS imaging if available. 

IVUS vs OCT para guiar la angioplastia ¿Cuál elegir?

There are no specific algorithms to guided PCI with OCT and neither is there much information on its relative benefits vs. IVUS.

The iSIGHT trial carried out by our Brazilian colleagues, recently published in Circulation Cardiovascular Interventions, has provided significant data on the matter, which makes us proud. 

All patients receiving PCI in at least one native lesion in coronary arteries between 2.25 and 4 mm in diameter, were randomized 1:1:1 to OCT, IVUS or angiography alone. 

An external elastic membrane–based protocol was applied for stent sizing in patients guided by IVUS and OCT.

The primary end point was non-inferiority of OCT vs IVUS to reach optimal stent expansion (minimum stent area ≥90% of the average reference lumen area)


Read also: Cerebral Protection Devices during TAVR in the Daily Practice.


It included 156 lesions (151 patients), 51 receiving OCT, 52 IVUS and 53 angiography.

Stent expansion with OCT (98.01 ± 16.14%) resulted non-inferior to the one obtained with IVUS (91.69 ± 15.75%) and superior to the angiography one (90.53 ± 14.84%, p=0.041).

Stent expansion obtained with IVUS was not superior to the one obtained with angiography alone (p=0.921). This should not discourage the use of IVUS, supported by significant evidence. 

Conclusion

Stent expansion with OCT based on an external elastic membrane–based protocol for stent sizing resulted non-inferior to the one obtained with IVUS and superior to the one obtained with angiography.

Original Title: Optical Coherence Tomography Versus Intravascular Ultrasound and Angiography to Guide Percutaneous Coronary Interventions. The iSIGHT Randomized Trial.

Reference: Daniel Chamié et al. Circulation: Cardiovascular Interventions. 2021;14:e009452. https://doi.org/10.1161/CIRCINTERVENTIONS.120.009452.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

ACC 2025 | FAME 3: FFR Guided PCI vs CABG 5 Year Outcomes.

Earlier studies comparing percutaneous coronary intervention (PCI) vs coronary artery bypass graft (CABG) have shown fewer events at long term for the surgical strategy.  However,...

CRABBIS Trial: Comparison of Different Provisional Stenting Sequences

Provisional stenting (PS) is the gold standard for percutaneous coronary intervention (PCI) in most patients with coronary bifurcation lesions (CBL). Moreover, recent studies such...

Andromeda Trial: Meta-Analysis of Drug Coated Balloon vs. DES in Small Vessel DeNovo Lesions

The use of coronary stents vs plain old balloon angioplasty (POBA), has allowed to reduce recoil and limiting flow dissection which were major limitation...

QFR vs. FFR: Is Coronary Revascularization Deferral Safe? Results from a FAVOR III Sub-Analysis

In cases of intermediate coronary lesions, functional assessment is recommended to aid the decision-making process regarding revascularization. There are several tools currently used to...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

ACC 2025 | FAME 3: FFR Guided PCI vs CABG 5 Year Outcomes.

Earlier studies comparing percutaneous coronary intervention (PCI) vs coronary artery bypass graft (CABG) have shown fewer events at long term for the surgical strategy.  However,...

ACC 2025 | API-CAT: Reduced vs. Full Dose Extended Anticoagulation in Patients with Cancer Related VTE

The risk of cancer related recurrent venous thromboembolism (VTE) will drop over time, while bleeding risk will persist. At present, it is recommended we...

STRIDE: Semaglutide in Patients with Peripheral Arterial Disease and Type II Diabetes

Peripheral arterial disease (PAD) is a severe complication in patients with type II diabetes, primarily affecting peripheral vessels, especially below-the-knee (BTK) arteries. This condition...